High-risk human papillomavirus seems not involved in DES-related and of limited importance in nonDES related clear-cell carcinoma of the cervix

Gynecol Oncol. 2011 Aug;122(2):297-302. doi: 10.1016/j.ygyno.2011.05.002. Epub 2011 May 26.

Abstract

Objective: Over 90% of all cervical adenocarcinoma are caused by a transforming infection with a high-risk type human papillomavirus (hrHPV). Previous studies demonstrated that the association between hrHPV positivity and cervical clear-cell adenocarcinoma (CCAC) varies between 0% and 100%. As approximately 60% of all CCAC are associated with intra-uterine diethylstilbestrol (DES) exposure, we determined in a cohort of both DES-exposed and DES-unexposed women the prevalence of hrHPV infections, and the potential etiological role of hrHPV by additional analysis of p16INK4a and p53 expression.

Methods: Representative slides of 28 women diagnosed with CCAC were tested for hrHPV by two PCR methods (the clinically validated GP5+/6+ PCR and the very sensitive SPF(10)PCR/LiPA(25)). Fifteen women were DES-exposed, 10 unexposed and of 3 women DES-exposure was unknown. Twenty-one cases with sufficient material were immuno-histochemically stained for p16INK4a and p53.

Results: Seven tumors, of which four DES-exposed and two unexposed tested positive for hrHPV with GP5+/6+ PCR. Thirteen tumors, of which five DES-exposed and seven unexposed, tested positive with SPF(10)PCR/LiPA(25). In one women with unknown exposure, a CCAC tested positive in both assays. Only three cases, none in DES-exposed women, and all positive with both hrHPV assays, revealed diffuse p16INK4a immuno-staining and weak p53 staining as well, supporting indisputable hrHPV involvement.

Conclusions: Although the prevalence of hrHPV was high, only two DES-unrelated CCAC (25%) and one tumor in a woman with unknown exposure could be attributed to hrHPV.

MeSH terms

  • Adenocarcinoma, Clear Cell / chemically induced
  • Adenocarcinoma, Clear Cell / etiology*
  • Adenocarcinoma, Clear Cell / virology
  • Adolescent
  • Adult
  • Cyclin-Dependent Kinase Inhibitor p16
  • Diethylstilbestrol / adverse effects*
  • Female
  • Humans
  • Immunohistochemistry
  • Middle Aged
  • Neoplasm Proteins / analysis
  • Papillomaviridae / isolation & purification*
  • Polymerase Chain Reaction
  • Pregnancy
  • Prenatal Exposure Delayed Effects*
  • Risk
  • Tumor Suppressor Protein p53 / analysis
  • Uterine Cervical Neoplasms / chemically induced
  • Uterine Cervical Neoplasms / etiology*
  • Uterine Cervical Neoplasms / virology

Substances

  • CDKN2A protein, human
  • Cyclin-Dependent Kinase Inhibitor p16
  • Neoplasm Proteins
  • Tumor Suppressor Protein p53
  • Diethylstilbestrol